FDA approves Agios’ AQVESME™ (mitapivat) for anemia in adults with thalassemia. It's an oral PK activator.Agios revealed that AQVESME™ (mitapivat), an oral pyruvate kinase (PK) activator, has received approval from the U.S. FDA for the treatment of thalassemia.
